EP2451284A4
Novel gold-based nanocrystals for medical treatments and electrochemical manufacturing processes therefor
240 sheets
Sheet 1 Sheet 2 Sheet 3 Sheet 4 Sheet 5 Sheet 6 Sheet 7 Sheet 8 Sheet 9 Sheet 10 Sheet 11 Sheet 12 Sheet 13 Sheet 14 Sheet 15 Sheet 16 Sheet 17 Sheet 18 Sheet 19 Sheet 20 Sheet 21 Sheet 22 Sheet 23 Sheet 24 Sheet 25 Sheet 26 Sheet 27 Sheet 28 Sheet 29 Sheet 30 Sheet 31 Sheet 32 Sheet 33 Sheet 34 Sheet 35 Sheet 36 Sheet 37 Sheet 38 Sheet 39 Sheet 40 Sheet 41 Sheet 42 Sheet 43 Sheet 44 Sheet 45 Sheet 46 Sheet 47 Sheet 48 Sheet 49 Sheet 50 Sheet 51 Sheet 52 Sheet 53 Sheet 54 Sheet 55 Sheet 56 Sheet 57 Sheet 58 Sheet 59 Sheet 60 Sheet 61 Sheet 62 Sheet 63 Sheet 64 Sheet 65 Sheet 66 Sheet 67 Sheet 68 Sheet 69 Sheet 70 Sheet 71 Sheet 72 Sheet 73 Sheet 74 Sheet 75 Sheet 76 Sheet 77 Sheet 78 Sheet 79 Sheet 80 Sheet 81 Sheet 82 Sheet 83 Sheet 84 Sheet 85 Sheet 86 Sheet 87 Sheet 88 Sheet 89 Sheet 90 Sheet 91 Sheet 92 Sheet 93 Sheet 94 Sheet 95 Sheet 96 Sheet 97 Sheet 98 Sheet 99 Sheet 100 Sheet 101 Sheet 102 Sheet 103 Sheet 104 Sheet 105 Sheet 106 Sheet 107 Sheet 108 Sheet 109 Sheet 110 Sheet 111 Sheet 112 Sheet 113 Sheet 114 Sheet 115 Sheet 116 Sheet 117 Sheet 118 Sheet 119 Sheet 120 Sheet 121 Sheet 122 Sheet 123 Sheet 124 Sheet 125 Sheet 126 Sheet 127 Sheet 128 Sheet 129 Sheet 130 Sheet 131 Sheet 132 Sheet 133 Sheet 134 Sheet 135 Sheet 136 Sheet 137 Sheet 138 Sheet 139 Sheet 140 Sheet 141 Sheet 142 Sheet 143 Sheet 144 Sheet 145 Sheet 146 Sheet 147 Sheet 148 Sheet 149 Sheet 150 Sheet 151 Sheet 152 Sheet 153 Sheet 154 Sheet 155 Sheet 156 Sheet 157 Sheet 158 Sheet 159 Sheet 160 Sheet 161 Sheet 162 Sheet 163 Sheet 164 Sheet 165 Sheet 166 Sheet 167 Sheet 168 Sheet 169 Sheet 170 Sheet 171 Sheet 172 Sheet 173 Sheet 174 Sheet 175 Sheet 176 Sheet 177 Sheet 178 Sheet 179 Sheet 180 Sheet 181 Sheet 182 Sheet 183 Sheet 184 Sheet 185 Sheet 186 Sheet 187 Sheet 188 Sheet 189 Sheet 190 Sheet 191 Sheet 192 Sheet 193 Sheet 194 Sheet 195 Sheet 196 Sheet 197 Sheet 198 Sheet 199 Sheet 200 Sheet 201 Sheet 202 Sheet 203 Sheet 204 Sheet 205 Sheet 206 Sheet 207 Sheet 208 Sheet 209 Sheet 210 Sheet 211 Sheet 212 Sheet 213 Sheet 214 Sheet 215 Sheet 216 Sheet 217 Sheet 218 Sheet 219 Sheet 220 Sheet 221 Sheet 222 Sheet 223 Sheet 224 Sheet 225 Sheet 226 Sheet 227 Sheet 228 Sheet 229 Sheet 230 Sheet 231 Sheet 232 Sheet 233 Sheet 234 Sheet 235 Sheet 236 Sheet 237 Sheet 238 Sheet 239 Sheet 240
Every citation, both ways
| Document | Relation | Office | Cited during |
|---|---|---|---|
| US2006068026A1 | Cites | United States of America | Search report |
| WO2006137851A2 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| US2006207388A1 | Cites | United States of America | Search report |
| US2009169807A1 | Cites | United States of America | Search report |
| WO2010083040A1 | Cites | World Intellectual Property Organization (WIPO) | Search report |
| WEIBO CAI ET AL: "Applications of gold nanoparticles in cancer nanotechnology", NANOTECHNOLOGY, SCIENCE AND APPLICATIONS, vol. 2008, 19 September 2008 (2008-09-19), pages 17 - 32, XP055092975, ISSN: 1177-8903 | Non-patent | – | Search report |
| See also references of WO 2011006007A1 | Non-patent | – | Search report |
53 members in 16 offices
Priority claims15
| Document | Office | Kind | Date |
|---|---|---|---|
| 223944P | United States of America | – | |
| 22394409 | United States of America | P | |
| 226153P | United States of America | – | |
| 22615309 | United States of America | P | |
| 228250P | United States of America | – | |
| 22825009 | United States of America | P | |
| 235574P | United States of America | – | |
| 23557409 | United States of America | P | |
| 249804P | United States of America | – | |
| 24980409 | United States of America | P | |
| 263648P | United States of America | – | |
| 26364809 | United States of America | P | |
| 294690P | United States of America | – | |
| 29469010 | United States of America | P | |
| 2010041427 | United States of America | W |
Members53
| Document | Office | Kind | |
|---|---|---|---|
| CA2767428A1 | Canada | A1 | |
| WO2011006007A1 | World Intellectual Property Organization (WIPO) | A1 | |
| SG177565A1 | Singapore | A1 | |
| IL217408A0 | Israel | A0 | |
| IL217408D0 | Israel | D0 | |
| AU2010271298A1 | Australia | A1 | |
| AU2010271298A2 | Australia | A2 | |
| EP2451284A1 | European Patent Office (EPO) | A1 | |
| KR20120052967A | Republic of Korea | A | |
| CN102548417A | China | A | |
| MX2012000489A | Mexico | A | |
| JP2012532992A | Japan | A | |
| RU2012104247A | Russian Federation | A | |
| US2013259903A1 | United States of America | A1 | |
| EP2451284A4This record | European Patent Office (EPO) | A4 | |
| SG10201403497QA | Singapore | A | |
| CN102548417B | China | B | |
| RU2568850C2 | Russian Federation | C2 | |
| AU2010271298B2 | Australia | B2 | |
| JP6059015B2 | Japan | B2 | |
| US9603870B2 | United States of America | B2 | |
| EP2451284B1 | European Patent Office (EPO) | B1 | |
| JP2017075390A | Japan | A | |
| DK2451284T3 | Denmark | T3 | |
| EP2451284B8 | European Patent Office (EPO) | B8 | |
| BR112012000311A2 | Brazil | A2 | |
| ES2623504T3 | Spain | T3 | |
| MX350309B | Mexico | B | |
| BR112012000311A8 | Brazil | A8 | |
| US2017348350A1 | United States of America | A1 | |
| IL217408A | Israel | A | |
| CA2767428C | Canada | C | |
| JP6383763B2 | Japan | B2 | |
| KR20180135119A | Republic of Korea | A | |
| KR101931381B1 | Republic of Korea | B1 | |
| JP2019014969A | Japan | A | |
| US10449217B2 | United States of America | B2 | |
| SG10201908339RA | Singapore | A | |
| KR102051248B1 | Republic of Korea | B1 | |
| KR20190133298A | Republic of Korea | A | |
| JP6703052B2 | Japan | B2 | |
| US2020188429A1 | United States of America | A1 | |
| KR102131575B1 | Republic of Korea | B1 | |
| JP2020128596A | Japan | A | |
| PH12017501884A1 | Philippines | A1 | |
| US10980832B2 | United States of America | B2 | |
| US2021236542A1 | United States of America | A1 | |
| SG10202108051XA | Singapore | A | |
| US2021361699A1 | United States of America | A1 | |
| BR112012000311B1 | Brazil | B1 | |
| JP7014851B2 | Japan | B2 | |
| MX2023013237A | Mexico | A | |
| MX2023013237A | Mexico | A |
92 legal events, as 13 offices reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | Office | |
|---|---|---|---|
| Full renewal or maintenance fee paidST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)U11 | U11 | CH | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Annual fee paid to national office [announced via postgrant information from national office to epo]GrantedPGFP | PGFP | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed because of non-payment of the annual feeLapsedMM | MM | BE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| No opposition filedOpposition26N | 26N | EP | |
| No opposition filed within time limitOppositionORIGINAL CODE: 0009261PLBE | PLBE | EP | |
| Information on the status of an ep patent application or granted ep patentGrantedSTATUS: NO OPPOSITION FILED WITHIN TIME LIMITSTAA | STAA | EP | |
| No opposition filed against granted patent, or epo opposition proceedings concluded without decisionGrantedR097 | R097 | DE | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Deletion acc. to par. 5 (withdrawal of the translation of the ep patent)MK05 | MK05 | AT | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Lapsed in a contracting state [announced via postgrant information from national office to epo]LapsedPG25 | PG25 | EP | |
| Fee paymentPLFP | PLFP | FR | |
| Definitive protectionFG2A | FG2A | ES | |
| Entry of ep patent into national phase of norway [publ. of translation]T2 | T2 | NO | |
| Translation of granted ep patentGrantedTRGR | TRGR | SE | |
| Dpma publication of mentioned ep patent grantGrantedR096 | R096 | DE | |
| Ep patent with danish claimsT3 | T3 | DK | |
| Translation for ep filed (entry of ep into country)FP | FP | NL | |
| European patents granted designating irelandGrantedFG4D | FG4D | IE | |
| Reference to at number (ep patent validated in austria)REF | REF | AT | |
| European patent takes effect as a national patent in ch/liEP | EP | CH | |
| New agentNV | NV | CH | |
| Designated contracting statesAK | AK | EP | |
| European patent grantedGrantedFG4D | FG4D | GB | |
| Party data changed (applicant data changed or rights of an application transferred)RAP1 | RAP1 | EP | |
| Correction requested after decision to grant or after decision to maintain patent in amended formORIGINAL CODE: EPIDOSNCDECGRAT | GRAT | EP | |
| (expected) grantORIGINAL CODE: 0009210GRAA | GRAA | EP | |
| Grant fee paidORIGINAL CODE: EPIDOSNIGR3GRAS | GRAS | EP | |
| Intention to grant announcedINTG | INTG | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Despatch of communication of intention to grant a patentORIGINAL CODE: EPIDOSNIGR1GRAP | GRAP | EP | |
| Amendment of ipc main classPREVIOUS MAIN CLASS: A01N0055020000R079 | R079 | DE | |
| First examination report despatched17Q | 17Q | EP | |
| Supplementary search report drawn up and despatchedA4 | A4 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Information provided on ipc code assigned before grantRIC1 | RIC1 | EP | |
| Request for extension of the european patent (deleted)DAX | DAX | EP | |
| Request for examination filed17P | 17P | EP | |
| Designated contracting statesAK | AK | EP | |
| Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI | PUAI | EP |
Numbers
- Publication
- 2451284
- Application
- 107978744
Titles3
- German
- NEUE NANOKRISTALLE AUF GOLDBASIS FÜR MEDIZINISCHE BEHANDLUNG UND ELEKTROCHEMISCHE HERSTELLUNGSVERFAHREN DAFÜR
- English
- NOVEL GOLD-BASED NANOCRYSTALS FOR MEDICAL TREATMENTS AND ELECTROCHEMICAL MANUFACTURING PROCESSES THEREFOR
- French
- NANOCRISTAUX À BASE D'OR INÉDITS UTILISABLES DANS LE CADRE DE TRAITEMENTS MÉDICAUX ET LEURS PROCÉDÉS ÉLECTROCHIMIQUES DE FABRICATION
Classification
- CPC, 57
- B22F9/00
- A61K9/08
- B82Y30/00
- C30B7/12
- C30B29/02
- C30B29/60
- A61K47/02
- A61K9/0095
- A61K9/14
- A61K9/10
- A61P1/04
- A61P1/16
- A61P11/00
- A61P11/02
- A61P11/06
- A61P17/04
- A61P19/00
- A61P19/02
- A61P19/06
- A61P19/10
- A61P21/00
- A61P21/04
- A61P25/00
- A61P25/04
- A61P25/14
- A61P25/16
- A61P25/28
- A61P27/02
- A61P29/00
- A61P29/02
- A61P31/04
- A61P31/06
- A61P31/12
- A61P31/16
- A61P31/20
- A61P33/00
- A61P33/06
- A61P35/00
- A61P35/02
- A61P35/04
- A61P37/00
- A61P37/02
- A61P37/06
- A61P37/08
- A61P5/14
- A61P9/00
- A61P9/10
- A61P3/10
- A61K33/242
- B22F1/0553
- B22F1/0545
- Y02A50/30
- B82B3/00
- A61K33/24
- A01N55/02
- A61K31/28
- C30B1/00
- IPC, 15
- A01N55 02
- A61K31 28
- C30B1 00
- B22F1 00
- A61K47 02
- A61K9 00
- A61K9 14
- B22F9 00
- A61K33 24
- B82Y30 00
- C30B7 12
- C30B29 60
- C30B29 02
- A61K33 242
- B22F1 0545
Designated states1
- Contracting states, 1
- Türkiye
